The American Pain Society released a white paper during its 35th Annual Scientific Meeting that provides guidance to pain physicians on cannabis-related issues. The report, also published in the Journal of Pain, calls for physicians to be aware of federal and state laws and be guided by scientific evidence.
UK researchers studying why chronic pain can persist found nerve damage linked to injury or disease can change epigenetic markers on some immune cells in the nervous systems of mice. The study was reported in Cell Reports.
Dr. Lucinda Grande of the University of Washington presented data at the APS 35th Annual Scientific Meeting comparing oral ketamine against a placebo for chronic pain in opioid-tolerant patients. Early data from a second study by a different research group suggested subanesthetic doses of intravenous ketamine used within 30 days of an amputation may help improve phantom limb pain.
A 69-patient study in the journal Brain found that exposure to a narrow spectrum of low-intensity green light may reduce light sensitivity and pain among migraine patients. Researchers said blue light made migraine pain worse for patients.
The House passed 18 measures last week meant to address rising opioid addiction and abuse rates, and lawmakers hope to send final legislation to President Barack Obama before leaving Capitol Hill for summer recess.
Community Care of West Virginia is trying to help patients with chronic pain deal with their conditions without relying on opioids, which can be addictive. The program shifted pain treatment from primary care doctors to an anesthesiologist, who is also a recovering opioid addict. His goal is to help those in the pain management program ease off the drugs, with lower doses and regular urine samples to make sure the medications aren't abused.
APS and Pfizer Independent Grants for Learning and Change (IGLC) have collaborated on in a new $2 million funding opportunity focused on improving care for individuals with chronic pain. It is the intent of this RFP to solicit applications related to the objectives in the National Pain Strategy (NPS), released last month by the Assistant Secretary of Health and Human Services (HHS). You have one month to submit -- this exciting opportunity will bring to light the topic of chronic pain and address the problems and objectives as articulated in the NPS. This RFP is being issued by APS with grant funding provided by Pfizer IGLC. Learn more.
APS supports professionals in the field who are working to increase the knowledge of pain and transform public policy and clinical practice. Members come from a broad spectrum of disciplines and work settings, including scientists, clinicians and other professionals. APS supports your professional development through quality education and opportunities for networking and volunteering to share knowledge and collaborate with the best and the brightest researchers and clinicians in the field. Become a member today!
The man who moves a mountain begins by carrying away small stones.